The cloud-based solutions for drug discovery, development and manufacturing market is projected to g
The growing complexities surrounding modern therapy development initiatives have caused biopharmaceutical companies to adopt available cloud-based solutions, to not only expedite associated timelines, but also cuts down overall cost
Roots Analysis has announced the addition of “Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market by Type of Cloud (Private, Public and Hybrid), Type of Service (Infrastructure as a Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS)), End-User (Biotech Vendors, Contract Research Organizations, Pharmaceutical Companies and Others), and Key Geographical Regions (North America, Europe, Asia, Middle East and North Africa, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings.
Modern cloud-based solutions offer decentralized / real world data management, and collaborative operating solutions to users, enabling the simplification and delegation of various aspects of data mining, analysis and healthcare decision-making. The implementation of relevant cloud-based solutions is deemed to possess the potential to save over 50% of the total cost and time invested in a drug development program.
To order this 225+ page report, which features 110+ figures and 130+ tables, please visit this link